缺乏单段大隐静脉时自体替代静脉用于腹股沟下旁路移植:单中心研究
单中心观察性研究纳入2019年4月至2023年2月间使用上肢静脉行腹股沟下旁路移植的48例患者共49条旁路,平均年龄68.1±9.8岁,男性32例(66.7%)。中位随访12.9个月(4.5-24.2),30天、1年、2年一期通畅率分别为93.7%±3.5%、84.8%±5.9%、80.6%±6.9%。作者认为将上肢静脉移植物整合入腹股沟下旁路实践安全且围手术期移植物失败率低。
要点
- 49条旁路中30天闭塞2条(4.1%),围手术期移植物失败率低。
- 1年一期通畅率84.8%±5.9%,2年一期通畅率80.6%±6.9%。
- 单段移植物1年二期通畅率100%±0%优于拼接移植物的87.6%±6.0%。
核心结论
- 将上肢静脉移植物整合入腹股沟下旁路实践可安全实施,围手术期移植物失败发生率低。
- 单段移植物的通畅率优于拼接静脉移植物。
- 所获得的早期通畅率和无截肢生存率强烈支持使用上肢静脉移植物。
- 在缺乏单段大隐静脉时,上肢静脉移植物应作为首选的管道选择。
研究设计与样本
- 单中心观察性研究,纳入2019年4月至2023年2月间所有使用上肢静脉行腹股沟下旁路移植的患者。
主要发现
- 研究期间48例患者共完成49条旁路,平均年龄68.1±9.8岁,男性32例(66.7%),体重指数28.0±4.8。
- 手术指征为慢性肢体威胁性缺血41条(83.7%)、急性肢体缺血3条(6.1%)、既往人工血管旁路并发症3条(6.1%)、既往自体旁路并发症2条(4.1%)。
- 43条(87.8%)旁路使用静脉拼接,其中3段移植物最常见(26条;53.1%)。
- 旁路类型为股胫24条(49.0%)、股腘11条(22.4%)、股足9条(18.4%)、延伸跳跃旁路5条(10.2%);18例(36.7%)为再次手术,21条(42.9%)仅使用上肢静脉。
- 中位随访12.9个月(4.5-24.2),术后30天内2条旁路闭塞(2/49;4.1%)。
关键数值与推荐
- 在缺乏单段大隐静脉时,上肢静脉移植物应作为首选的管道选择(作者结论)。
临床怎么用
- 作者认为,缺乏单段大隐静脉时,上肢静脉移植物应作为首选的管道选择。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Alternative autologous veins can be used as a conduit when adequate great saphenous vein is unavailable. We analyzed the results of our infrainguinal bypasses after adopting upper extremity veins in our practice. METHODS: This is a single-center observational study involving all patients whose infrainguinal bypass involved the use of upper extremity veins between April 2019, when we began using arm veins, and February 2023. RESULTS: During the study period, 49 bypasses were done in 48 patients; mean age 68.1 ± 9.8; men 32 (66.7%); body mass index 28.0 ± 4.8; indications for surgery: chronic limb threatening ischemia 41 (83.7%); acute limb ischemia 3 (6.1%); complications of previous prosthetic 3 (6.1%), or autologous 2 (4.1%) bypass grafts. Vein splicing was used in 43 (87.8%) bypasses with 3-segment grafts being the most common (26; 53.1%). There were 24 (49.0%) femorotibial, 11 (22.4%) femoropopliteal, 9 (18.4%) femoropedal, and 5 (10.2%) extension jump bypass procedures. Eighteen (36.7%) operations were redo surgeries. Twenty-one (42.9%) bypasses were formed using only arm veins. The median follow-up was 12.9 months (4.5-24.2). Two bypasses occluded during the first 30 postoperative days (2/49; 4.1%). Overall 30-day, 1-year, and 2-year primary patency rates were 93.7% ± 3.5%, 84.8% ± 5.9%, and 80.6% ± 6.9%, and secondary patency (SP) rates were 95.8% ± 2.9%, 89.2% ± 5.3%, and 89.2% ± 5.3%. One-segment grafts had better patencies than 2-, 3-, and 4-segment grafts (1-year SP 100% ± 0% vs 87.6% ± 6.0%). Two-year amputation-free survival was 86.8% ± 6.5%; 2-year overall survival was 88.2% ± 6.6%. CONCLUSIONS: Integration of arm vein grafts in infrainguinal bypass practice can be done safely with low incidences of perioperative graft failure. One-segment grafts had better patencies than spliced vein grafts. The achieved early patency and amputation-free survival rates strongly encourage their use. In the absence of a single-segment great saphenous vein, upper extremity vein grafts should be the preferred conduit choice.
引用
- Biroš E, Staffa R, Krejčí M, et al. Autologous Alternative Vein Grafts for Infrainguinal Bypass in the Absence of Single-Segment Great Saphenous Vein: A Single-Center Study. Ann Vasc Surg. 2024. PMID: 38428452. doi:10.1016/j.avsg.2023.12.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。